Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Zimmer M.,,Inhibition of Hypoxia-Inducible Factor Is Sufficient for Growth Suppression of VHL-/- Tumors,2004,Molecular Cancer Research,198,,United States,Article,Boston,0,Journal,2-s2.0-1342280515
Kondo K.,,Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth.,2003,PLoS biology.,429,,United States,Article,Boston,0,Journal,2-s2.0-2342597973
Gunaratnam L.,,Hypoxia Inducible Factor Activates the Transforming Growth Factor-α/Epidermal Growth Factor Receptor Growth Stimulatory Pathway in VHL<sup>-/-</sup> Renal Cell Carcinoma Cells,2003,Journal of Biological Chemistry,164,10.1074/jbc.M305502200,Canada,Article,Ottawa,1,Journal,2-s2.0-0242581718
Yang J.,,"A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer",2003,New England Journal of Medicine,2420,10.1056/NEJMoa021491,United States;United States,Article,Bethesda;Bethesda,0,Journal,2-s2.0-0042343801
Dannenberg H.,,Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas,2003,International Journal of Cancer,27,10.1002/ijc.11060,Netherlands,Article,Rotterdam,0,Journal,2-s2.0-0037431550
Li Z.,,The VHL protein recruits a novel KRAB-A domain protein to repress HIF-1α transcriptional activity,2003,EMBO Journal,65,10.1093/emboj/cdg173,United States,Article,Rochester,0,Journal,2-s2.0-0037446951
Jiang Y.,,Gene expression profiling in a renal cell carcinoma cell line: Dissecting VHL and hypoxia-dependent pathways,2003,Molecular Cancer Research,115,,United States,Article,Framingham,0,Journal,2-s2.0-0037395395
Maynard M.,,Multiple splice variants of the human HIF-3α locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex,2003,Journal of Biological Chemistry,211,10.1074/jbc.M208681200,Canada,Article,Toronto,1,Journal,2-s2.0-0037837724
Kuznetsova A.,,Von Hippel-Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination,2003,Proceedings of the National Academy of Sciences of the United States of America,167,10.1073/pnas.0436037100,United States,Article,Cincinnati,1,Journal,2-s2.0-0344838401
Eng C.,,A role for mitochondrial enzymes in inherited neoplasia and beyond,2003,Nature Reviews Cancer,300,10.1038/nrc1013,United Kingdom;United States,Review,Cambridge;Columbus,0,Journal,2-s2.0-0037364314
Pastore Y.D.,,Mutations in the VHL gene in sporadic apparently congenital polycythemia,2003,Blood,128,10.1182/blood-2002-06-1843,,Article,,0,Journal,2-s2.0-0037441601
Drevs J.,,Receptor tyrosine kinases: The main targets for new anticancer therapy,2003,Current Drug Targets,86,10.2174/1389450033346885,Germany,Review,Freiberg am Neckar,0,Journal,2-s2.0-0037313867
Schnell P.,,Regulation of tyrosine hydroxylase promoter activity by the von Hippel-Lindau tumor suppressor protein and hypoxia-inducible transcription factors,2003,Journal of Neurochemistry,79,10.1046/j.1471-4159.2003.01696.x,United States,Article,Cincinnati,0,Journal,2-s2.0-0037389490
Hergovich A.,,Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL,2003,Nature Cell Biology,274,10.1038/ncb899,Switzerland,Article,Basel,0,Journal,2-s2.0-0037223823
Rebar E.,,Induction of angiogenesis in a mouse model using engineered transcription factors,2002,Nature Medicine,223,10.1038/nm1202-795,United States,Article,Richmond,0,Journal,2-s2.0-0036912846
Ang S.,,Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia,2002,Nature Genetics,386,10.1038/ng1019,United States;United States,Article,Birmingham;Houston,0,Journal,2-s2.0-18744373593
Pavlovich C.,,Renal tumors in the Birt-Hogg-Dubé syndrome,2002,American Journal of Surgical Pathology,427,10.1097/00000478-200212000-00002,United States,Article,Bethesda,0,Journal,2-s2.0-0036892633
Zhou M.I.,,The von Hippel-Lindau tumor suppressor stabilizes novel plant homeodomain protein Jade-1,2002,Journal of Biological Chemistry,65,10.1074/jbc.M205040200,United States,Article,Boston,1,Journal,2-s2.0-0037131189
Ivan M.,,Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor,2002,Proceedings of the National Academy of Sciences of the United States of America,453,10.1073/pnas.192342099,United States,Article,Boston,1,Journal,2-s2.0-0037108807
Gijtenbeek J.,,Analysis of von Hippel-Lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: Possible genetic heterogeneity,2002,Journal of Neurosurgery,23,10.3171/jns.2002.97.4.0977,Netherlands,Article,Nijmegen,0,Journal,2-s2.0-0036800998
Maher E.R.,,The pressure rises: Update on the genetics of phaeochromocytoma,2002,Human Molecular Genetics,144,10.1093/hmg/11.20.2347,United Kingdom,Review,Birmingham,1,Journal,2-s2.0-0036798174
Gimenez-Roqueplo A.,,Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma,2002,Journal of Clinical Endocrinology and Metabolism,189,10.1210/jc.2002-020525,France,Article,Paris,1,Journal,2-s2.0-0036774422
Fabbro D.,,Targeting protein kinases in cancer therapy,2002,Current Opinion in Drug Discovery and Development,55,,Switzerland,Review,Basel,0,Journal,2-s2.0-0036771375
Aiello L.,,Rapid and durable recovery of visual function in a patient with von Hippel-Lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor SU5416,2002,Ophthalmology,108,10.1016/S0161-6420(02)01159-4,United States;United States,Article,Boston;Boston,0,Journal,2-s2.0-0036712736
Igarashi H.,,Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma,2002,Cancer,60,10.1002/cncr.10635,Japan,Article,Tokyo,0,Journal,2-s2.0-0036645598
Zatyka M.,,Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease,2002,Cancer Research,143,,United Kingdom,Article,Birmingham,0,Journal,2-s2.0-0036645091
Lando D.,,FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor,2002,Genes and Development,1057,10.1101/gad.991402,Australia,Article,Adelaide,1,Journal,2-s2.0-0037097861
Min J.,,Structure of an HIF-1α-pVHL complex: Hydroxyproline recognition in signaling,2002,Science,514,10.1126/science.1073440,United States,Article,Chevy Chase,0,Journal,2-s2.0-0037035851
Bindra R.S.,,VHL-mediated hypoxia regulation of cyclin D1 in renal carcinoma cells,2002,Cancer Research,104,,United States,Article,Bethesda,0,Journal,2-s2.0-0036606006
Richard S.,,Paradoxical secondary polycythemia in von Hippel-Lindau patients treated with anti-vascular endothelial growth factor receptor therapy,2002,Blood,47,10.1182/blood.V99.10.3851,United States;France;France;France;France,Article,San Francisco;Paris;Paris;Paris;Le Kremlin-Bicetre,0,Journal,2-s2.0-0037092958
Esteban-Barragán M.A.,,Role of the von Hippel-Lindau tumor suppressor gene in the formation of β1-integrin fibrillar adhesions,2002,Cancer Research,69,,Spain,Article,Madrid,0,Journal,2-s2.0-0037093099
Neumann H.P.H.,,Germ-line mutations in nonsyndromic pheochromocytoma,2002,New England Journal of Medicine,1074,10.1056/NEJMoa020152,Germany;Germany,Article,Freiburg im Breisgau;Freiburg im Breisgau,0,Journal,2-s2.0-0037046659
Sang N.,,"Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1α is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP",2002,Molecular and Cellular Biology,130,10.1128/MCB.22.9.2984-2992.2002,United States,Article,Philadelphia,1,Journal,2-s2.0-0036232662
Singh A.,,Solitary retinal capillary hemangioma: Lack of genetic evidence for von Hippel-Lindau disease,2002,Ophthalmic Genetics,14,10.1076/opge.23.1.21.2201,United States,Article,Philadelphia,0,Journal,2-s2.0-0036205412
Kondo K.,,Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: Relationship to clinicopathological parameters,2002,Genes Chromosomes and Cancer,190,10.1002/gcc.10054,Japan,Article,Yokohama,0,Journal,2-s2.0-18344396226
Bauer A.,,Endogenous von Hippel-Lindau tumor suppressor protein regulates catecholaminergic phenotype in PC12 cells,2002,Cancer Research,13,,United States,Article,Cincinnati,0,Journal,2-s2.0-0037086279
Li Z.,,Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein,2002,Journal of Biological Chemistry,124,10.1074/jbc.M108269200,United States,Article,Rochester,1,Journal,2-s2.0-0037085456
Lando D.,,Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch,2002,Science,1169,10.1126/science.1068592,Australia,Article,Adelaide,0,Journal,2-s2.0-0036469038
Wiesener M.,,"Erythropoietin, tumours and the von Hippel-Lindau gene: Towards identification of mechanisms and dysfunction of oxygen sensing",2002,Nephrology Dialysis Transplantation,13,10.1093/ndt/17.3.356,Germany,Article,Berlin,1,Journal,2-s2.0-0036194474
Hamano K.,,Biallelic inactivation of the von Hippel-Lindau tumor suppressor gene in sporadic renal cell carcinoma,2002,Journal of Urology,36,10.1097/00005392-200202000-00071,Japan,Article,Tokyo,0,Journal,2-s2.0-0036143370
Li Z.,,Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel-Lindau tumor suppressor,2002,Biochemical and Biophysical Research Communications,93,10.1016/S0006-291X(02)00534-X,United States,Article,Rochester,0,Journal,2-s2.0-0036290499
Mandriota S.J.,,HIF activation identifies early lesions in VHL kidneys: Evidence for site-specific tumor suppressor function in the nephron,2002,Cancer Cell,374,10.1016/S1535-6108(02)00071-5,United Kingdom,Article,Oxford,1,Journal,2-s2.0-17044452288
Maranchie J.K.,,The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinoma,2002,Cancer Cell,372,10.1016/S1535-6108(02)00044-2,United States,Article,Bethesda,1,Journal,2-s2.0-0036527785
Hon W.C.,,Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL,2002,Nature,481,10.1038/nature00767,United Kingdom,Article,Oxford,0,Journal,2-s2.0-18444368709
Kondo K.,,Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein,2002,Cancer Cell,598,10.1016/S1535-6108(02)00043-0,United States,Article,Boston,1,Journal,2-s2.0-0036528246
Nickerson M.,,"Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome",2002,Cancer Cell,621,10.1016/S1535-6108(02)00104-6,United States,Article,Frederick,1,Journal,2-s2.0-0000939691
Tomlinson I.P.M.,,"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer the multiple leiomyoma consortium",2002,Nature Genetics,1016,10.1038/ng849,United Kingdom,Article,London,0,Journal,2-s2.0-18544365990
Okuda H.,,The von Hippel-Lindau Tumor Suppressor Protein Mediates Ubiquitination of Activated Atypical Protein Kinase C,2001,Journal of Biological Chemistry,138,10.1074/jbc.M107880200,Japan,Article,Nankoku,1,Journal,2-s2.0-0035941291
Bruick R.,,A conserved family of prolyl-4-hydroxylases that modify HIF,2001,Science,1911,10.1126/science.1066373,United States,Article,Dallas,0,Journal,2-s2.0-0035834409
Mahon P.C.,,FIH-1: A novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity,2001,Genes and Development,975,10.1101/gad.924501,United States,Article,Baltimore,1,Journal,2-s2.0-0035887011
Elson D.,,Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1α,2001,Genes and Development,269,10.1101/gad.914801,United States,Article,San Francisco,1,Journal,2-s2.0-0035476509
Masson N.,,Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation,2001,EMBO Journal,779,10.1093/emboj/20.18.5197,United Kingdom,Article,Oxford,0,Journal,2-s2.0-0035903468
Taylor M.,,Characterization and comparative analysis of the EGLN gene family,2001,Gene,119,10.1016/S0378-1119(01)00633-3,United Kingdom,Article,Edinburgh,0,Journal,2-s2.0-0035812318
Yu F.,,HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation,2001,Proceedings of the National Academy of Sciences of the United States of America,590,10.1073/pnas.181341498,United States,Article,Philadelphia,1,Journal,2-s2.0-0035859692
Wiesener M.S.,,Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1α in clear cell renal carcinomas,2001,Cancer Research,293,,Germany,Article,Berlin,0,Journal,2-s2.0-0035394516
Milunsky J.,,Novel mutations and the emergence of a common mutation in the SDHD gene causing familial paraganglioma,2001,American Journal of Medical Genetics,70,10.1002/ajmg.1270,United States;United States,Article,Boston;Boston,0,Journal,2-s2.0-0035874016
Hoffman M.A.,,Von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF,2001,Human Molecular Genetics,304,10.1093/hmg/10.10.1019,United States,Article,Boston,0,Journal,2-s2.0-0035336706
Clifford S.,,Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis invon Hippel-Lindau disease,2001,Human Molecular Genetics,312,,United Kingdom;United Kingdom,Article,Birmingham;Newcastle,0,Journal,2-s2.0-0035339044
Ivan M.,,HIFα targeted for VHL-mediated destruction by proline hydroxylation: Implications for O<inf>2</inf> sensing,2001,Science,3427,10.1126/science.1059817,United States,Article,Chevy Chase,0,Journal,2-s2.0-0035917313
Jaakkola P.,,Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O<inf>2</inf>-regulated prolyl hydroxylation,2001,Science,3908,10.1126/science.1059796,United Kingdom,Article,Oxford,0,Journal,2-s2.0-0035917808
Semenza G.,,HIF-1 and mechanisms of hypoxia sensing,2001,Current Opinion in Cell Biology,760,10.1016/S0955-0674(00)00194-0,United States,Review,Baltimore,0,Journal,2-s2.0-0035313697
De Paulsen N.,,Role of transforming growth factor-α in von Hippel-Lindau (VHL)<sup>-/-</sup> clear cell renal carcinoma cell proliferation: A possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis,2001,Proceedings of the National Academy of Sciences of the United States of America,182,10.1073/pnas.031587498,Canada,Article,Ottawa,0,Journal,2-s2.0-0035852630
Haase V.,,Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor,2001,Proceedings of the National Academy of Sciences of the United States of America,317,10.1073/pnas.98.4.1583,United States;United States,Article,Cambridge;Boston,1,Journal,2-s2.0-0035852668
Davidowitz E.,,VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling,2001,Molecular and Cellular Biology,94,10.1128/MCB.21.3.865-874.2001,United States,Article,New York,1,Journal,2-s2.0-0035136533
Gläsker S.,,Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system,2001,Journal of Neurology Neurosurgery and Psychiatry,56,10.1136/jnnp.70.5.644,Germany,Article,Freiburg im Breisgau,1,Journal,2-s2.0-0035033789
Gimenez-Roqueplo A.,,The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway,2001,American Journal of Human Genetics,299,10.1086/324413,France,Article,Paris,1,Journal,2-s2.0-0035213138
Wykoff C.C.,,Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling,2000,Oncogene,231,10.1038/sj.onc.1204012,United Kingdom,Article,Oxford,1,Journal,2-s2.0-0034649507
Bender B.,,Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas,2000,Journal of Clinical Endocrinology and Metabolism,88,10.1210/jc.85.12.4568,Germany;Germany,Article,Freiburg im Breisgau;Freiburg im Breisgau,0,Journal,2-s2.0-0034485464
Krieg M.,,Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function,2000,Oncogene,292,10.1038/sj.onc.1203938,Germany,Article,Freiburg im Breisgau,1,Journal,2-s2.0-0034676331
Vincent K.,,Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1α/VP16 hybrid transcription factor,2000,Circulation,278,10.1161/01.CIR.102.18.2255,United States,Article,Cambridge,1,Journal,2-s2.0-0034739533
Ohh M.,,Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel - Lindau protein,2000,Nature Cell Biology,1142,10.1038/35017054,United States,Article,Boston,0,Journal,2-s2.0-0033776536
Kamura T.,,Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex,2000,Proceedings of the National Academy of Sciences of the United States of America,510,10.1073/pnas.190332597,United States,Article,Oklahoma City,1,Journal,2-s2.0-0034641615
Drevs J.,,"Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model",2000,Cancer Research,306,,Germany,Article,Freiberg am Neckar,0,Journal,2-s2.0-0034282515
Cockman M.,,Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein,2000,Journal of Biological Chemistry,854,10.1074/jbc.M002740200,United Kingdom,Article,London,1,Journal,2-s2.0-0034682783
Tanimoto K.,,Mechanism of regulation of the hypoxia-inducible factor-la by the von Hippel-Lindau tumor suppressor protein,2000,EMBO Journal,647,,Sweden,Article,Stockholm,0,Journal,2-s2.0-0034663894
Datta K.,,Inhibition of insulin-like growth factor-I-mediated cell signaling by the von Hippel-Lindau gene product in renal cancer,2000,Journal of Biological Chemistry,76,10.1074/jbc.M909970199,United States,Article,Boston,1,Journal,2-s2.0-0034617086
Zagzag D.,,"Expression of hypoxia-inducible factor 1α in brain tumors: Association with angiogenesis, invasion, and progression",2000,Cancer,521,10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W,United States,Article,New York,1,Journal,2-s2.0-0034213146
Brauch H.,,VHL alterations in human clear cell renal cell carcinoma: Association with advanced tumor stage and a novel hot spot mutation,2000,Cancer Research,189,,Germany,Article,Stuttgart,0,Journal,2-s2.0-16744366213
Baysal B.,,"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma",2000,Science,1266,10.1126/science.287.5454.848,United States,Article,Pittsburgh,0,Journal,2-s2.0-0034602950
Chandel N.S.,,"Cellular oxygen sensing by mitochondria: Old questions, new insight",2000,Journal of Applied Physiology,326,10.1152/jappl.2000.88.5.1880,United States,Review,Chicago,0,Journal,2-s2.0-0034082278
Kamura T.,,The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2,1999,Genes and Development,223,10.1101/gad.13.22.2928,United States,Article,Oklahoma City,1,Journal,2-s2.0-0032727343
Deshaies R.,,SCF and cullin/RING H2-based ubiquitin ligases,1999,Annual Review of Cell and Developmental Biology,1037,10.1146/annurev.cellbio.15.1.435,United States,Review,Pasadena,0,Book Series,2-s2.0-0033279836
Iwai K.,,Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex,1999,Proceedings of the National Academy of Sciences of the United States of America,394,10.1073/pnas.96.22.12436,Japan,Article,Kyoto,1,Journal,2-s2.0-0033607291
Kroll S.,,von Hippel-Lindau protein induces hypoxia-regulated arrest of tyrosine hydroxylase transcript elongation in pheochromocytoma cells,1999,Journal of Biological Chemistry,44,10.1074/jbc.274.42.30109,United States,Article,Cincinnati,1,Journal,2-s2.0-0033570052
Okuda H.,,Direct interaction of the β-domain of VHL tumor suppressor protein with the regulatory domain of atypical PKC isotypes,1999,Biochemical and Biophysical Research Communications,78,10.1006/bbrc.1999.1347,Japan,Article,Nankoku,0,Journal,2-s2.0-0033600881
Lisztwan J.,,The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity,1999,Genes and Development,319,10.1101/gad.13.14.1822,Switzerland,Article,Basel,1,Journal,2-s2.0-0033565672
Maxwell P.H.,,The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis,1999,Nature,3704,10.1038/20459,United Kingdom,Article,Oxford,0,Journal,2-s2.0-0033587146
Stebbins C.E.,,Structure of the VHL-elonginC-elonginB complex: Implications for VHL tumor suppressor function,1999,Science,641,10.1126/science.284.5413.455,United States,Article,New York,0,Journal,2-s2.0-0033574737
Ema M.,,Molecular mechanisms of transcription activation by HLF and HIF1α in response to hypoxia: Their stabilization and redox signal-induced interaction with CBP/p300,1999,EMBO Journal,471,,Japan,Article,Sendai,0,Journal,2-s2.0-0033118983
Kallio P.,,Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway,1999,Journal of Biological Chemistry,659,10.1074/jbc.274.10.6519,Sweden,Article,Stockholm,1,Journal,2-s2.0-0033525830
Webster A.R.,,A clinical and molecular genetic analysis of solitary ocular angioma,1999,Ophthalmology,43,10.1016/S0161-6420(99)90127-6,United Kingdom;United Kingdom;United Kingdom,Article,Cambridge;Cambridge;London,0,Journal,2-s2.0-0033506427
Blankenship C.,,Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity,1999,Oncogene,98,10.1038/sj.onc.1202473,United States;United States,Article,Waltham;Princeton,1,Journal,2-s2.0-0033602089
Stephen L.,,Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein,1999,Molecular and Cellular Biology,110,10.1128/mcb.19.2.1486,Canada;United States,Article,Ottawa;Bethesda,1,Journal,2-s2.0-0344026345
Gallou C.,,Mutations of the VHL gene in sporadic renal cell carcinoma: Definition of a risk factor for VHL patients to develop an RCC,1999,Human Mutation,113,10.1002/(SICI)1098-1004(1999)13:6<464::AID-HUMU6>3.0.CO;2-A,France,Article,Paris,0,Journal,2-s2.0-0032970571
Koochekpour S.,,The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells,1999,Molecular and Cellular Biology,176,10.1128/MCB.19.9.5902,United States,Article,Frederick,1,Journal,2-s2.0-0032795938
Olschwang S.,,Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma,1998,Human Mutation,79,10.1002/(SICI)1098-1004(1998)12:6<424::AID-HUMU9>3.0.CO;2-H,France,Article,Paris,0,Journal,2-s2.0-0031762403
Stolle C.,,Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene,1998,Human Mutation,381,10.1002/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K,United States,Article,Philadelphia,0,Journal,2-s2.0-7844234770
Kallio P.,,Signal transduction in hypoxic cells: Inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1α,1998,EMBO Journal,499,,Sweden,Article,Stockholm,0,Journal,2-s2.0-0032538797
Lieubeau-Teillet B.,,von Hippel-Lindau gene-mediated growth suppression and induction of differentiation in renal cell carcinoma cells grown as multicellular tumor spheroids,1998,Cancer Research,72,,Canada;Canada,Article,Toronto;Toronto,0,Journal,2-s2.0-0032211360
Tian H.,,The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development,1998,Genes and Development,477,10.1101/gad.12.21.3320,United States,Article,Dallas,1,Journal,2-s2.0-0032213236
Pal S.,,Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C ζ,1998,Journal of Biological Chemistry,155,10.1074/jbc.273.41.26277,United States,Article,Boston,1,Journal,2-s2.0-0032500637
Iliopoulos O.,,pVHL<inf>19</inf> is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation,1998,Proceedings of the National Academy of Sciences of the United States of America,193,10.1073/pnas.95.20.11661,United States,Article,Boston,1,Journal,2-s2.0-0032578357
Ye Y.,,Subcellular localization of the von Hippel-Lindau disease gene product is cell cycle-dependent,1998,International Journal of Cancer,35,10.1002/(SICI)1097-0215(19980925)78:1<62::AID-IJC11>3.0.CO;2-7,United States,Article,Cleveland,1,Journal,2-s2.0-0031869573
Schoenfeld A.,,"A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor",1998,Proceedings of the National Academy of Sciences of the United States of America,180,10.1073/pnas.95.15.8817,United States,Article,New York,1,Journal,2-s2.0-0032555217
Van der Harst E.,,Germline mutations in the vhl gene in patients presenting with phaeochromocytomas,1998,International Journal of Cancer,71,10.1002/(SICI)1097-0215(19980729)77:3<337::AID-IJC5>3.0.CO;2-P,Netherlands,Article,Rotterdam,0,Journal,2-s2.0-2642668463
Huang L.,,Regulation of hypoxia-inducible factor 1α is mediated by an O<inf>2</inf>-dependent degradation domain via the ubiquitin-proteasome pathway,1998,Proceedings of the National Academy of Sciences of the United States of America,1719,10.1073/pnas.95.14.7987,United States,Article,Boston,1,Journal,2-s2.0-0032493368
Pause A.,,The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal,1998,Proceedings of the National Academy of Sciences of the United States of America,207,10.1073/pnas.95.3.993,United States;,Article,Bethesda;,1,Journal,2-s2.0-0032477788
Lee J.,,Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas,1998,Cancer Research,124,,South Korea,Article,Seoul,0,Journal,2-s2.0-18844474899
Knebelmann B.,,Transforming growth factor α is a target for the von Hippel-Lindau tumor suppressor,1998,Cancer Research,155,,United States,Article,Boston,0,Journal,2-s2.0-0031964099
Flamme I.,,Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF/HIF-2α,1998,American Journal of Pathology,91,10.1016/S0002-9440(10)65541-1,Germany,Article,Koln,0,Journal,2-s2.0-0031870653
Clifford S.C.,,Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: Evidence for a VHL-independent pathway in clear cell renal tumourigenesis,1998,Genes Chromosomes and Cancer,237,10.1002/(sici)1098-2264(199807)22:3<200::aid-gcc5>3.0.co;2-%23,United Kingdom;United Kingdom,Article,Cambridge;Birmingham,0,Journal,2-s2.0-0031776704
Lonergan K.M.,,Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2,1998,Molecular and Cellular Biology,309,10.1128/MCB.18.2.732,United States;United States,Article,Boston;Boston,1,Journal,2-s2.0-0031907152
Ohh M.,,The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix,1998,Molecular Cell,383,10.1016/S1097-2765(00)80096-9,United States,Article,Boston,1,Journal,2-s2.0-0032085240
Gnarra J.,,Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice,1997,Proceedings of the National Academy of Sciences of the United States of America,274,10.1073/pnas.94.17.9102,United States;United States,Article,New Orleans;Bethesda,1,Journal,2-s2.0-0030847165
Benjamin L.,,Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels bv VEGF withdrawal,1997,Proceedings of the National Academy of Sciences of the United States of America,430,10.1073/pnas.94.16.8761,Israel,Article,Jerusalem,1,Journal,2-s2.0-0030806273
Pugh C.W.,,Activation of hypoxia-inducible factor-1; Definition of regulatory domains within the α subunit,1997,Journal of Biological Chemistry,425,10.1074/jbc.272.17.11205,United Kingdom,Article,Oxford,1,Journal,2-s2.0-0030937718
Teh B.,,Familial non-VHL non-papillary clear-cell renal cancer [3],1997,Lancet,50,10.1016/S0140-6736(05)61751-5,,Article,,0,Journal,2-s2.0-0030992453
Pause A.,,"The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins",1997,Proceedings of the National Academy of Sciences of the United States of America,409,10.1073/pnas.94.6.2156,United States,Article,Bethesda,1,Journal,2-s2.0-0030953635
Bar M.,,Sporadic phaeochromocytoma are rarely associated with germline mutations in the von Hippel-Lindau and RET genes,1997,Clinical Endocrinology,51,10.1046/j.1365-2265.1997.3251150.x,Israel,Article,Jerusalem,0,Journal,2-s2.0-0031298741
Tse J.,,Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas,1997,American Journal of Clinical Pathology,54,10.1093/ajcp/107.4.459,Hong Kong,Article,,1,Journal,2-s2.0-0031003674
Stratmann R.,,Putative control of angiogenesis in hemangioblastomas by the von Hippel- Lindau tumor suppressor gene,1997,Journal of Neuropathology and Experimental Neurology,66,10.1097/00005072-199711000-00009,Germany,Article,Freiburg im Breisgau,1,Journal,2-s2.0-0030831655
Brauch H.,,Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene,1997,Journal of Clinical Endocrinology and Metabolism,73,10.1210/jc.82.12.4101,Germany,Article,Hamburg,0,Journal,2-s2.0-0030781576
Vortmeyer A.O.,,von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease,1997,Human Pathology,162,10.1016/S0046-8177(97)90075-7,,Article,,0,Journal,2-s2.0-0030958304
Schmidt L.,,Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas,1997,Nature Genetics,1196,10.1038/ng0597-68,United States,Article,Frederick,0,Journal,2-s2.0-17344381429
Lubensky I.,,Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients,1996,American Journal of Pathology,165,,United States,Article,Bethesda,0,Journal,2-s2.0-0029847090
Zbar B.,,"Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan",1996,Human Mutation,420,10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3,United States,Article,Bethesda,0,Journal,2-s2.0-16144365122
Renbaum P.,,Isolation and characterization of the full-length 3' untranslated region of the human von Hippel-Lindau tumor suppressor gene,1996,Human Genetics,35,10.1007/s004390050281,United States;Israel,Article,Frederick;Jerusalem,0,Journal,2-s2.0-0029859624
Hofstra R.,,Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases,1996,Journal of Clinical Endocrinology and Metabolism,69,10.1210/jc.81.8.2881,Netherlands,Article,Groningen,0,Journal,2-s2.0-10144242640
Gnarra J.,,Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene,1996,Proceedings of the National Academy of Sciences of the United States of America,451,10.1073/pnas.93.20.10589,United States,Article,Bethesda,1,Journal,2-s2.0-0029785838
Iliopoulos O.,,Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein,1996,Proceedings of the National Academy of Sciences of the United States of America,693,10.1073/pnas.93.20.10595,United States,Article,Boston,1,Journal,2-s2.0-0029785321
Zhuang Z.,,Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens,1996,Modern Pathology,36,,United States,Article,Bethesda,0,Journal,2-s2.0-0029759214
Chang B.,,"SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box",1996,Cell,895,10.1016/S0092-8674(00)80098-7,United States,Article,Houston,1,Journal,2-s2.0-0030602813
Oberstraß J.,,Mutation of the von Hippel-Lindau tumour suppressor gene in capillary haemangioblastomas of the central nervous system,1996,Journal of Pathology,71,10.1002/(SICI)1096-9896(199606)179:2<151::AID-PATH556>3.0.CO;2-0,Germany,Article,Dusseldorf,0,Journal,2-s2.0-0029893946
Kenck C.,,Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas,1996,Journal of Pathology,86,10.1002/(SICI)1096-9896(199606)179:2<157::AID-PATH557>3.0.CO;2-S,Germany,Article,Heidelberg,0,Journal,2-s2.0-0029944971
Siemeister G.,,Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein,1996,Cancer Research,278,,Germany,Article,Freiberg am Neckar,0,Journal,2-s2.0-0029920054
Richards F.,,Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis,1996,Human Molecular Genetics,81,10.1093/hmg/5.5.639,United Kingdom,Article,Cambridge,1,Journal,2-s2.0-0029926989
Lee S.,,Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density,1996,Proceedings of the National Academy of Sciences of the United States of America,130,10.1073/pnas.93.5.1770,United States,Article,Bethesda,1,Journal,2-s2.0-0029946004
Zhuang Z.,,Von Hippel-Lindau disease gene deletion detected in microdissected sporadic human colon carcinoma specimens,1996,Human Pathology,40,10.1016/S0046-8177(96)90368-8,United States,Article,Bethesda,0,Journal,2-s2.0-0030025951
Böhling T.,,Expression of growth factors and growth factor receptors in capillary hemangioblastoma,1996,Journal of Neuropathology and Experimental Neurology,85,10.1097/00005072-199605000-00004,Finland,Article,Helsinki,1,Journal,2-s2.0-0030006001
Kishida T.,,Cellular Proteins That Bind the von Hippel-Lindau Disease Gene Product: Mapping of Binding Domains and the Effect of Missense Mutations,1995,Cancer Research,137,,United States,Article,Frederick,0,Journal,2-s2.0-0028826589
Kibel A.,,Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C,1995,Science,534,10.1126/science.7660130,United States,Article,Boston,0,Journal,2-s2.0-0029147430
Duan D.,,"Characterization of the VHL tumor suppressor gene product: Localization, complex formation, and the effect of natural inactivating mutations",1995,Proceedings of the National Academy of Sciences of the United States of America,133,10.1073/pnas.92.14.6459,United States,Article,Bethesda,1,Journal,2-s2.0-0029028652
Wizigmann-Voos S.,,Up-Regulation of Vascular Endothelial Growth Factor and Its Receptors in von Hippel-Lindau Disease-associated and Sporadic Hemangioblastomas,1995,Cancer Research,307,,Germany,Article,Freiburg im Breisgau,0,Journal,2-s2.0-0028929991
Brauch H.,,"Von Hippel-Lindau disease and sporadic renal cell carcinoma. Review of pathogenesis, morphological spectrum and molecular genetics",1995,Pathologe,2,10.1007/s002920050109,Germany,Review,Munich,0,Journal,2-s2.0-0029027937
Foster K.,,Molecular genetic analysis of the von Hippel-Lindau disease (VHl) tumour suppressor gene in gonadal tumours,1995,European Journal of Cancer,21,10.1016/0959-8049(95)00437-8,United Kingdom,Article,Cambridge,0,Journal,2-s2.0-0029563795
Reifenberger G.,,Coexpression of transforming growth factor-α and epidermal growth factor receptor in capillary hemangioblastomas of the central nervous system,1995,American Journal of Pathology,41,,Sweden,Article,Stockholm,0,Journal,2-s2.0-0029153743
Eng C.,,Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas,1995,Journal of Medical Genetics,162,10.1136/jmg.32.12.934,United Kingdom;United States,Article,Cambridge;Boston,1,Journal,2-s2.0-0028788184
Chen F.,,Germline mutations in the von Hippel–Lindau disease tumor suppressor gene: Correlations with phenotype,1995,Human Mutation,440,10.1002/humu.1380050109,United States,Article,Frederick,0,Journal,2-s2.0-0028981766
Duan D.,,Inhibition of transcription elongation by the VHL tumor suppressor protein,1995,Science,492,10.1126/science.7660122,United States,Article,Bethesda,0,Journal,2-s2.0-0029126892
Iliopoulos O.,,Tumour suppression by the human von hippel-lindau gene product,1995,Nature Medicine,553,10.1038/nm0895-822,United States,Article,Boston,0,Journal,2-s2.0-0029090338
Whaley J.,,Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma,1994,American Journal of Human Genetics,200,,United States,Article,New York,0,Journal,2-s2.0-0027986502
Foster K.,,Somatic mutations of the von hippel - lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma,1994,Human Molecular Genetics,303,10.1093/hmg/3.12.2169,United Kingdom,Article,Cambridge,0,Journal,2-s2.0-0028587585
Herman J.G.,,Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma,1994,Proceedings of the National Academy of Sciences of the United States of America,1311,10.1073/pnas.91.21.9700,United States,Article,Baltimore,1,Journal,2-s2.0-0028072991
Shuin T.,,Frequent Somatic Mutations and Loss of Heterozygosity of the von Hippel-Lindau Tumor Suppressor Gene in Primary Human Renal Cell Carcinomas,1994,Cancer Research,441,,United States;Japan;Japan,Article,Frederick;Yokohama;Yokohama,0,Journal,2-s2.0-0028235907
Zhuang Z.,,Detection of the von Hippel-Lindau gene deletion in cytologic specimens using microdissection and the polymerase chain reaction,1994,Acta Cytologica,12,,United States,Article,Bethesda,0,Journal,2-s2.0-0028141839
Kanno H.,,Somatic Mutations of the Von Hippel-Lindau Tumor Suppressor Gene in Sporadic Central Nervous System Hemangioblastomas,1994,Cancer Research,200,,Japan,Article,Yokohama,0,Journal,2-s2.0-0027938458
Takahashi A.,,Markedly Increased Amounts of Messenger RNAs for Vascular Endothelial Growth Factor and Placenta Growth Factor in Renal Cell Carcinoma Associated with Angiogenesis,1994,Cancer Research,391,,Japan,Article,Chuo-ku,0,Journal,2-s2.0-0027933191
Gnarra J.,,Mutations of the VHL tumour suppressor gene in renal carcinoma,1994,Nature Genetics,1398,10.1038/ng0594-85,United States,Article,Bethesda,0,Journal,2-s2.0-0027954044
Brown L.,,Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas,1993,American Journal of Pathology,571,,United States,Article,Boston,0,Journal,2-s2.0-0027768808
Morii K.M.,,Expression of vascular endothelial growth factor in capillary hemangioblastoma,1993,Biochemical and Biophysical Research Communications,85,10.1006/bbrc.1993.1885,Japan,Article,Niigata,0,Journal,2-s2.0-0027320270
Latif F.,,Identification of the von Hippel-Lindau disease tumor suppressor gene,1993,Science,2289,10.1126/science.8493574,United States,Article,Frederick,0,Journal,2-s2.0-0027240519
Mydlo J.H.,,Expression of Transforming Growth Factor α and Epidermal Growth Factor Receptor Messenger RNA in Neoplastic and Nonneoplastic Human Kidney Tissue,1989,Cancer Research,156,,United States,Article,New York,0,Journal,2-s2.0-0024328825
Seizinger B.R.,,Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma,1988,Nature,504,10.1038/332268a0,United States,Article,Boston,0,Journal,2-s2.0-0023865666
Burk J.R.,,Renal ceil carcinoma with erythrocytosis and elevated erythropoietic stimulatory activity,1977,Southern Medical Journal,7,10.1097/00007611-197708000-00017,United States;United States,Article,New Orleans;Dallas,0,Journal,2-s2.0-0017653532
Golde D.W.,,Polycythemia vera: hormonal modulation of erythropoiesis in vitro,1977,Blood,37,10.1182/blood.v49.3.399.bloodjournal493399,United States,Article,Los Angeles,1,Journal,2-s2.0-0017347539
Arias-Stella J.,,Chief cell hyperplasia in the human carotid body at high altitudes: Physiologic and pathologic significance,1976,Human Pathology,131,10.1016/S0046-8177(76)80052-4,,Article,,0,Journal,2-s2.0-0017179154
Knudson A.,,Heredity and cancer in man.,1973,Progress in medical genetics,187,,,Review,,0,Journal,2-s2.0-0015549929
Kawafuchi J.i.,,"Hematological study on a case with cerebellar hemangioblastoma associated with erythrocytosis, with special reference to a erythropoiesis-stimulating activity present in the fluid of the cyst of tumor",1970,Blut Zeitschrift für die Gesamte Blutforschung,11,10.1007/BF01632856,Japan,Article,Maebashi,0,Journal,2-s2.0-0014736416
LINDAU A.,,ZUR FRAGE DER ANGIOMATOSIS RETINæ UND IHRER HIRNKOMPLIKATIONEN,1926,Acta Ophthalmologica,84,10.1111/j.1755-3768.1926.tb07786.x,Sweden,Article,Lund,0,Journal,2-s2.0-0000768725
v. Hippel E.,,Über eine sehr seltene Erkrankung der Netzhaut - Klinische Beobachtungen,1904,Albrecht von Græfe's Archiv für Ophthalmologie,168,10.1007/BF01994821,Germany,Article,Heidelberg,0,Journal,2-s2.0-34347163881
